ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 058,96
-0,08%
Dow Jones
38 386,09
0,38%
DAX
18 067,52
-0,35%
Brent Oil
87,185
-0,11%
Bitcoin
62 849,21
-1,55%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) Actualités

NVRO Nevro Corp

11,42
0,00 (0,00%)
30 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Nevro Corp NVRO NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 11,42 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
11,42
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/4/202414:30PRNUSNevro to Report First-Quarter 2024 Financial Results and..
11/3/202421:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:10PRNUSNevro Receives FDA 510(k) Clearance to Use SI Fixation..
23/2/202423:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/2/202422:11EDGAR2Form 8-K - Current report
21/2/202422:09EDGAR2Form 8-K - Current report
21/2/202422:06PRNUSNevro Enters Into Cooperation Agreement With Engaged Capital
21/2/202422:05PRNUSNevro Reports Fourth-Quarter and Full-Year 2023 Financial..
14/2/202421:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202421:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202422:30PRNUSNevro Announces Consensus Statement Supporting..
29/1/202422:30PRNUSNevro to Report Fourth-Quarter and Full-Year 2023 Financial..
18/1/202422:15PRNUSNevro Announces Positive Coverage Update from Carelon..
17/1/202422:15PRNUSNevro to Highlight 25 Scientific Abstracts at 2024 North..
11/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/1/202423:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/1/202414:41EDGAR2Form 8-K - Current report
09/1/202414:30PRNUSNevro Announces Preliminary Fourth-Quarter and Full-Year..
08/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:15PRNUSNevro to Present at 42nd Annual J.P. Morgan Healthcare..
03/1/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
05/12/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202312:07EDGAR2Form 8-K - Current report
30/11/202323:19PRNUSNevro Announces Acquisition of Vyrsa™ Technologies
30/11/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202313:00PRNUSNevro Delivers Long-Term Relief with High-Frequency Spinal..
15/11/202300:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:07EDGAR2Form 8-K - Current report
01/11/202321:01PRNUSNevro Reports Third Quarter 2023 Financial Results, Provides..
06/10/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202313:00PRNUSNevro to Report Third Quarter 2023 Financial Results
03/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202313:00PRNUSNew Data Demonstrate the Health Economic Benefits of Nevro's..
06/9/202323:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NYSE
NVRO
Nevro
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés